179 related articles for article (PubMed ID: 9535725)
1. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor.
Kosai K; Matsumoto K; Nagata S; Tsujimoto Y; Nakamura T
Biochem Biophys Res Commun; 1998 Mar; 244(3):683-90. PubMed ID: 9535725
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice.
Kosai K; Matsumoto K; Funakoshi H; Nakamura T
Hepatology; 1999 Jul; 30(1):151-9. PubMed ID: 10385651
[TBL] [Abstract][Full Text] [Related]
3. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.
Rodriguez I; Matsuura K; Ody C; Nagata S; Vassalli P
J Exp Med; 1996 Nov; 184(5):2067-72. PubMed ID: 8920897
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.
Fornoni A; Li H; Foschi A; Striker GE; Striker LJ
Am J Pathol; 2001 Jan; 158(1):275-80. PubMed ID: 11141501
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
[TBL] [Abstract][Full Text] [Related]
6. Lethal hepatic apoptosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sensitization in mice.
Nagaki M; Sugiyama A; Osawa Y; Naiki T; Nakashima S; Nozawa Y; Moriwaki H
J Hepatol; 1999 Dec; 31(6):997-1005. PubMed ID: 10604572
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1beta protects mice from Fas-mediated hepatocyte apoptosis and death.
Takehara T; Hayashi N; Tatsumi T; Kanto T; Mita E; Sasaki Y; Kasahara A; Hori M
Gastroenterology; 1999 Sep; 117(3):661-8. PubMed ID: 10464143
[TBL] [Abstract][Full Text] [Related]
8. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
9. A Novel AKT Activator, SC79, Prevents Acute Hepatic Failure Induced by Fas-Mediated Apoptosis of Hepatocytes.
Liu W; Jing ZT; Wu SX; He Y; Lin YT; Chen WN; Lin XJ; Lin X
Am J Pathol; 2018 May; 188(5):1171-1182. PubMed ID: 29673487
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor alpha protects against Fas-mediated liver apoptosis in mice.
Kanda D; Takagi H; Toyoda M; Horiguchi N; Nakajima H; Otsuka T; Mori M
FEBS Lett; 2002 May; 519(1-3):11-5. PubMed ID: 12023010
[TBL] [Abstract][Full Text] [Related]
11. Protein-tyrosine phosphatase 1B deficiency protects against Fas-induced hepatic failure.
Sangwan V; Paliouras GN; Cheng A; Dubé N; Tremblay ML; Park M
J Biol Chem; 2006 Jan; 281(1):221-8. PubMed ID: 16234234
[TBL] [Abstract][Full Text] [Related]
12. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice.
Leu JI; Crissey MA; Taub R
J Clin Invest; 2003 Jan; 111(1):129-39. PubMed ID: 12511596
[TBL] [Abstract][Full Text] [Related]
13. TAT-apoptosis repressor with caspase recruitment domain protein transduction rescues mice from fulminant liver failure.
An J; Harms C; Lättig-Tünnemann G; Sellge G; Mandić AD; Malato Y; Heuser A; Endres M; Trautwein C; Donath S
Hepatology; 2012 Aug; 56(2):715-26. PubMed ID: 22392694
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.
Lacronique V; Mignon A; Fabre M; Viollet B; Rouquet N; Molina T; Porteu A; Henrion A; Bouscary D; Varlet P; Joulin V; Kahn A
Nat Med; 1996 Jan; 2(1):80-6. PubMed ID: 8564847
[TBL] [Abstract][Full Text] [Related]
15. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection.
Rodriguez I; Matsuura K; Khatib K; Reed JC; Nagata S; Vassalli P
J Exp Med; 1996 Mar; 183(3):1031-6. PubMed ID: 8642244
[TBL] [Abstract][Full Text] [Related]
16. Hypothermia inhibits Fas-mediated apoptosis of primary mouse hepatocytes in culture.
Fu T; Blei AT; Takamura N; Lin T; Guo D; Li H; O'Gorman MR; Soriano HE
Cell Transplant; 2004; 13(6):667-76. PubMed ID: 15648737
[TBL] [Abstract][Full Text] [Related]
17. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.
de la Coste A; Fabre M; McDonell N; Porteu A; Gilgenkrantz H; Perret C; Kahn A; Mignon A
Am J Physiol; 1999 Sep; 277(3):G702-8. PubMed ID: 10484397
[TBL] [Abstract][Full Text] [Related]
18. Differential activity of bcl-2 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells.
Schlapbach R; Fontana A
Biochim Biophys Acta; 1997 Nov; 1359(2):174-80. PubMed ID: 9409814
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
[TBL] [Abstract][Full Text] [Related]
20. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).
Huang DC; Hahne M; Schroeter M; Frei K; Fontana A; Villunger A; Newton K; Tschopp J; Strasser A
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14871-6. PubMed ID: 10611305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
